Search Results 641-650 of 18916 for Neoplasm
Patients with high-risk myeloproliferative neoplasms (systemic mastocytosis [SM], advanced symptomatic hypereosinoophic disorder [PED], myelofibrosis [MF], and ...
... neoplasms and to determine the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) of E7386. A Study of CDX-1127 (Varlilumab) in Patients ...
In about 1 of every 5 breast cancers, the cancer cells have extra copies of the gene that makes the HER2 protein. HER2 -positive breast cancers tend to be more ...
cancer, Appendix cancer, Gastrointestinal stromal tumor, Appendiceal mucinous neoplasm, Retroperitoneal sarcoma. Show more areas of focus for Sara K. Daniel ...
Molecular markers for the diagnosis and prognostication of myeloid neoplasms; Molecular test development and improvement; Bleeding and thrombotic disorders ...
Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis. Blood Adv. 2023 Nov 28; 7 (22):7007-7016
Participation eligibility · adequately treated basal cell or squamous cell carcinoma of the skin; · superficial bladder cancer; · prostate intraepithelial neoplasm ...
... Neoplastic meningitis, Diffuse glioma, Pilocytic astrocytoma, Plexiform neurofibroma, Diffuse midline glioma. Show more areas of focus for Maciej M. Mrugala ...
Intracranial neoplasms and paraneoplastic disorders. In: Adams and Victor's Principles of Neurology. 12th ed. McGraw Hill; 2023. https://accessmedicine ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.